Astellas Receives Complete Response Letter From FDA for Izervay SNDA

Seeking Alpha09:09 ET

Jefferies Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating, Cuts Target Price to $57

Moomoo News08:32 ET · Ratings

Apellis Pharmaceuticals (APLS) Receives a Buy From Jefferies

TipRanks07:56 ET · Ratings

Piper Sandler Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Maintains Target Price $32

Moomoo News07:33 ET · Ratings

Piper Sandler Remains a Hold on Apellis Pharmaceuticals (APLS)

TipRanks06:47 ET · Ratings

Wells Fargo Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Maintains Target Price $30

Moomoo News06:31 ET · Ratings